Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,200 | -29,340 | -19,120 | -9,660 | -27,370 |
| Depreciation Amortization | 5,630 | 3,710 | 2,430 | 1,270 | 4,740 |
| Other Working Capital | -8,650 | -8,110 | -6,680 | -3,740 | 6,440 |
| Other Operating Activity | 8,400 | 5,700 | 3,200 | 1,710 | -3,190 |
| Operating Cash Flow | $-29,820 | $-28,040 | $-20,170 | $-10,420 | $-19,380 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,300 | -2,130 | -1,860 | -670 | -11,170 |
| Other Investing Activity | 78,960 | 23,680 | 25,620 | 12,660 | 6,670 |
| Investing Cash Flow | $72,660 | $21,550 | $23,760 | $11,990 | $-4,500 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 5,480 | 5,930 | 670 | -30 | 21,070 |
| Financing Cash Flow | $5,480 | $5,930 | $670 | $-30 | $21,070 |
| Exchange Rate Effect | 2,480 | 100 | 260 | 40 | -760 |
| Beginning Cash Position | 1,010 | 1,010 | 1,010 | 1,010 | 4,590 |
| End Cash Position | 51,820 | 560 | 5,540 | 2,590 | 1,010 |
| Net Cash Flow | $50,800 | $-450 | $4,520 | $1,580 | $-3,570 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,820 | -28,040 | -20,170 | -10,420 | -19,380 |
| Free Cash Flow | -29,820 | -28,040 | -20,170 | -10,420 | -19,380 |